TY  - GEN
AU  - Geisler,Tobias
AU  - Poli,Sven
AU  - Meisner,Christoph
AU  - Schreieck,Juergen
AU  - Zuern,Christine S
AU  - Nägele,Thomas
AU  - Brachmann,Johannes
AU  - Jung,Werner
AU  - Gahn,Georg
AU  - Schmid,Elisabeth
AU  - Bäezner,Hansjörg
AU  - Keller,Timea
AU  - Petzold,Gabor C
AU  - Schrickel,Jan-Wilko
AU  - Liman,Jan
AU  - Wachter,Rolf
AU  - Schön,Frauke
AU  - Schabet,Martin
AU  - Lindner,Alfred
AU  - Ludolph,Albert C
AU  - Kimmig,Hubert
AU  - Jander,Sebastian
AU  - Schlegel,Uwe
AU  - Gawaz,Meinrad
AU  - Ziemann,Ulf
TI  - Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): Rationale and study design
SN  - 1747-4949
PY  - 2018///0613
KW  - Aspirin
KW  - therapeutic use
KW  - Brain
KW  - diagnostic imaging
KW  - Embolism
KW  - Factor Xa Inhibitors
KW  - Fibrinolytic Agents
KW  - Humans
KW  - Pyrazoles
KW  - Pyridones
KW  - Research Design
KW  - Secondary Prevention
KW  - Stroke
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1177/1747493016681019
ER  -